Source: Eur Respir J, 57 (2) 2004347; 10.1183/13993003.04347-2020
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Onofre Moran-Mendoza, Mohamed Khalil. Comment on: Bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: a systematic review and meta-analysis. Eur Respir J, 57 (2) 2004347; 10.1183/13993003.04347-2020

Member's Comments

No comment yet.

Related content which might interest you: Bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: a systematic review and meta-analysis Source: Eur Respir J, 56 (2) 2000206; 10.1183/13993003.00206-2020 Year: 2020 The perpetual enigma of bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: is it of diagnostic value? Source: Eur Respir J, 56 (2) 2001534; 10.1183/13993003.01534-2020 Year: 2020 Severe asthma in children: shall we carry out systematic bronchoalveolar lavage? Source: Virtual Congress 2021 – Early-life infections, wheezing and asthma Year: 2021 Refractory severe asthma: Is presence of aspergillus in broncho-alveolar lavage significant? Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues Year: 2015 Bronchoalveolar lavage fluid findings in children with hypersensitivity pneumonitis Source: Eur Respir J 2003; 21: 144-148 Year: 2003 Retrospective assessment of pulmonary sarcoidosis with the aid of bronchoalveolar lavage (BAL) during the past three-year period in a general hospital Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Bronchoalveolar lavage findings and disease progression in hypersensitivity pneumonitis Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Hypersensitivity pneumonitis: etiological correlation to bronchoalveolar lavage and functional impairment Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Bronchoalveolar lavage fluid cytokines in the assessment of interstitial lung disease in systemic sclerosis: a prospective study Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Utility of bronchoalveolar lavage in vasculitis patients Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Prognostic impact of bronchoalveolar lavage lymphocytosis in patients with chronic Hypersensitivity Pneumonitis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management Year: 2018 Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: A prospective study in pediatric patients Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Source: Eur Respir J 2011; 38: 761-769 Year: 2011 Bronchoalveolar lavage in severe persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 584s Year: 2002 The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 The role of the combined assessment of the bronchoalveolar lavage (BAL) and radiological profile in the diagnosis of chronic eosinophilic pneumonia (CEP) Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013 Bronchoalveolar lavage findings in children with chronic cough Source: Eur Respir J 2001; 18: Suppl. 33, 191s Year: 2001 Accelerated silicosis: A report of three patients Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Clinical approach to pulmonary sarcoidosis Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016